Found 0 matching trials
ORCA - Oracea® for Rosacea: A Community-based Assessment PHASE4 The objective of this study is to assess the effectiveness, safety, subject...
Show More Location
REGISTRAT® - MAP1, Inc. (CRO)
Learn More & Join Trial
A Phase 1/2a Study Evaluating Allocetra-OTS as Monotherapy or in Combination With Anti-PD-1 Therapy for the Treatment of Advanced Solid Tumor Malignancy PHASE1 This is an open-label, non-randomized, multicenter, Phase 1/2a study to eva...
Show More Location
Rambam Medical Center
Learn More & Join Trial
Real-World Study of the Safety and Efficacy of Surufatinib in the Treatment of Neuroendocrine Tumors N/A Prior clinical trials have demonstrated promising efficacy and manageable s...
Show More Location
The First Affiliated Hospital of Xiamen University
Learn More & Join Trial
A Study of the CD73 Inhibitor LY3475070 Alone or in Combination With Pembrolizumab in Participants With Advanced Cancer PHASE1 The reason for this study is to see if the CD73 inhibitor LY3475070 alone o...
Show More Location
Sarah Cannon Research Institute at HealthOne
Learn More & Join Trial
LME-Guided Precision Combination Therapy in B-cell Lymphoma Patients After CD19 CAR-T Failure PHASE2 This study evaluates a personalized treatment strategy for patients with la...
Show More Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai,
Learn More & Join Trial
Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy PHASE3 Study N01175 was to compare overall effectiveness (efficacy and safety) of ...
Show More Location
Multiple Locations
Learn More & Join Trial
Cost- Effectiveness and Quality of Life Assessment in Mood Disorder PHASE4 To evaluate the effectiveness of three systematic interventions for Bipolar...
Show More Location
Multiple Locations
Learn More & Join Trial
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers PHASE1 TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion cl...
Show More Location
Arizona Oncology Associates
Learn More & Join Trial
Biomarker Analysis in High PD-L1 Expressing NSCLC Patients Treated With PD-1/PD-L1 Based Therapy With or Without the Addition of Platinum Based Chemotherapy N/A This Observational study will explore the utility of the Biodesix, Inc. "PI...
Show More Location
Addario Lung Cancer Medical Institute (ALCMI)
Learn More & Join Trial
Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005) PHASE3 Researchers are looking for new ways to treat people with endometrial cance...
Show More Status
Active Not Recruiting
Location
USA Mitchell Cancer Institute ( Site 4142)
Learn More & Join Trial